{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Bleomycin",
  "nciThesaurus": {
    "casRegistry": "11056-06-7",
    "chebiId": "CHEBI:3139",
    "chemicalFormula": "",
    "definition": "A mixture of glycopeptide antineoplastic antibiotics isolated from the bacterium Streptomyces verticillus. Bleomycin forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals which cause single- and double-stranded breaks in DNA; these reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation.",
    "fdaUniiCode": "40S1VHN69B",
    "identifier": "C313",
    "preferredName": "Bleomycin",
    "semanticType": "Antibiotic",
    "subclassOf": [
      "C2311"
    ],
    "synonyms": [
      "BLEO",
      "BLEOMYCIN",
      "BLM",
      "Bleo",
      "Bleomycin",
      "bleomycin"
    ]
  }
}